INOVIO Receives Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candida | INO Message Board Posts


Inovio Biomedical Corporation

  INO website

INO   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  2134 of 2142  at  8/28/2021 11:06:04 AM  by

billmax


 In response to msg 2133 by  co3aii
view thread

Re: INOVIO Receives Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800

 I made a profit with INO but about 1/2 of what I could have by getting too greedy.  I was in INO way before Covid.  I learned a lot from management the last year and not much is encouraging, the reason why I only hold a small amount today. My major sector today is Energy.  


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 0  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
2135 Re: INOVIO Receives Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800 co3aii 0 8/28/2021 1:04:45 PM


Financial Market Data provided by
.
Loading...